How much stock should otolaryngologists put into the parental interpretations of their child’s complaints? According to Ellen M. Friedman, MD, an otolaryngologist in Houston, parental descriptions are an important part of patient histories, but you still need to perform objective measures.
A new era in efforts to treat patients with tissue loss or organ failure is under way, which has the potential to revolutionize the treatment of many diseases and conditions that otolaryngologists treat.
Endoscopic sinus surgery was introduced into the United States more than 20 years ago; over that time period it has undergone significant changes, in terms of both surgical technique and our understanding of the disorder of chronic rhinosinusitis.
Not long ago, physicians routinely decried evidence-based medicine (EBM) as an encroachment on their professional autonomy, a barrier to good patient care, insensitive to health care’s growing complexity, and at odds with the transcendent value of the physician-patient relationship.
Although voice therapy is commonly used as an initial treatment for vocal fold nodules, its role in the treatment of vocal fold polyps and cysts is less defined.
Obstructive sleep apnea (OSA) needs to be addressed as a multilevel disease, especially in patients who fail or can’t tolerate continuous positive airway pressure (CPAP).
Although functional endoscopic sinus surgery (FESS) is a commonly used and well-established tool for the treatment of chronic rhinosinusitis, between 10% and 20% of patients will have recurrent disease and require further surgery.
A regimen of six weekly shots of a novel vaccine may be an effective long-term approach for patients with allergic rhinitis, sparing them injections once or twice a week for three to five years, according to results of a pilot study published recently in the New England Journal of Medicine.